Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A comprehensive list of world equity market indices to help you quickly locate major benchmarks and understand their regional focus.
28,379 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
As 2026 unfolds, a mix of rate shifts, debt pressures, and geopolitical strains create a tricky path for investors. T...
Ready to invest $10,000 in energy? This guide argues for a top-tier, cash-flow-driven pick and shows you how to maxim...
The Vatican has established a dedicated AI commission as Pope Leo XIV prepares a papal encyclical on AI ethics with A...
Ford stock has momentum, but the decision to buy isn’t straightforward. This article breaks down the case for and aga...
The quantum race isn’t only about qubits. Behind every breakthrough is a critical, unglamorous layer of infrastructur...
In the race to dominate AI inference, two hardware contenders stand out: Nvidia and Cerebras. This guide breaks down ...
Walmart has enjoyed a powerful start to the year, but can the rally last? This article breaks down the factors behind...
Is GameStop stock a buy, hold, or sell in today’s market? This practical guide walks you through the current dynamics...
A billionaire’s online rant against a respected paper can ripple through markets and wallets. This article explains w...
A leaked document outlines a SpaceX strategy to move AI compute to orbit, potentially reshaping investment bets acros...
Income-focused investors are tuning in to Energy Transfer for a high-yield dividend and steady growth. This guide exp...